| Mr Bradley Robert Nicol, MD | |
|
823 N San Francisco St, Suite F, Flagstaff, AZ 86001 | |
| (928) 226-7667 | |
| (928) 226-7664 |
| Full Name | Mr Bradley Robert Nicol |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 28 Years |
| Location | 823 N San Francisco St, Flagstaff, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669447488 | NPI | - | NPPES |
| 701690 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 30127 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Flagstaff Medical Center | Flagstaff, AZ | Hospital |
| Verde Valley Medical Center | Cottonwood, AZ | Hospital |
| Entity Name | Flagstaff Neurosurgery Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073850582 PECOS PAC ID: 7618116799 Enrollment ID: O20130621000052 |
News Archive
GlaxoSmithKline (GSK) and Aptuit, Inc. announced today that they have finalized an agreement for Aptuit to acquire operations at GSK's Medicines Research Centre in Verona, Italy. The arrangement, which is effective as of July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with R&D services from the facilities. Financial terms have not been disclosed.
Clearbridge Accelerator announced today that it has received an investment from Tim Draper, a well-established venture capitalist based in the Silicon Valley.
According to a new report by researchers from UK, the population of Papua New Guinea has the greatest linguistic and genetic diversity. The language differences across the bends of the river Sepik are baffling and reflect and underlying genetic diversity that was until now not fully appreciated. The study report is published today 15th of September 2017 in the journal Science.
Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) announced today that an independent data monitoring committee (IDMC) has recommended the early termination of its Phase 3, 52-week, placebo-controlled, intramuscular depot aripiprazole trial.
› Verified 3 days ago
| Entity Name | Northern Arizona Healthcare Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669914552 PECOS PAC ID: 3577473362 Enrollment ID: O20170801003409 |
News Archive
GlaxoSmithKline (GSK) and Aptuit, Inc. announced today that they have finalized an agreement for Aptuit to acquire operations at GSK's Medicines Research Centre in Verona, Italy. The arrangement, which is effective as of July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with R&D services from the facilities. Financial terms have not been disclosed.
Clearbridge Accelerator announced today that it has received an investment from Tim Draper, a well-established venture capitalist based in the Silicon Valley.
According to a new report by researchers from UK, the population of Papua New Guinea has the greatest linguistic and genetic diversity. The language differences across the bends of the river Sepik are baffling and reflect and underlying genetic diversity that was until now not fully appreciated. The study report is published today 15th of September 2017 in the journal Science.
Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) announced today that an independent data monitoring committee (IDMC) has recommended the early termination of its Phase 3, 52-week, placebo-controlled, intramuscular depot aripiprazole trial.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Bradley Robert Nicol, MD 823 N San Francisco St, Suite F, Flagstaff, AZ 86001 Ph: (928) 226-7667 | Mr Bradley Robert Nicol, MD 823 N San Francisco St, Suite F, Flagstaff, AZ 86001 Ph: (928) 226-7667 |
News Archive
GlaxoSmithKline (GSK) and Aptuit, Inc. announced today that they have finalized an agreement for Aptuit to acquire operations at GSK's Medicines Research Centre in Verona, Italy. The arrangement, which is effective as of July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with R&D services from the facilities. Financial terms have not been disclosed.
Clearbridge Accelerator announced today that it has received an investment from Tim Draper, a well-established venture capitalist based in the Silicon Valley.
According to a new report by researchers from UK, the population of Papua New Guinea has the greatest linguistic and genetic diversity. The language differences across the bends of the river Sepik are baffling and reflect and underlying genetic diversity that was until now not fully appreciated. The study report is published today 15th of September 2017 in the journal Science.
Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) announced today that an independent data monitoring committee (IDMC) has recommended the early termination of its Phase 3, 52-week, placebo-controlled, intramuscular depot aripiprazole trial.
› Verified 3 days ago
Stephen L Ritland, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 107 E Oak Ave, Flagstaff, AZ 86001 Phone: 928-779-7880 Fax: 928-779-7895 | |
David J. Sacco, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 150 N Verde St, Suite 101, Flagstaff, AZ 86001 Phone: 928-779-0588 Fax: 928-779-2358 | |
Sam Safavi-abbasi, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1300 N Rim Dr Ste A, Flagstaff, AZ 86001 Phone: 928-226-7667 Fax: 928-226-7664 |